根据生物信息学和实验分析,确定CCDC115作为肝癌的不良预后生物标志物

Chang Su1,2, Jing-Cheng Yang1, Zheng Rong1

  • 1Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, Air Force Military Medical University, Xi'an, China.

Heliyon
|September 7, 2023
PubMed
概括

卷曲卷曲域含有蛋白115 (CCDC115) 在肝肝细胞癌 (LIHC) 中被上调,并与预后不佳有关. 准CCDC115可能会提高LIHC治疗疗效.